Survey of Prevalence of Loss of Appetite in Subject With Health Disorders

Appetite Clinical Trial

— SPLASH  

Official title:

Survey of Prevalence of Loss of Appetite in Subject With Health Disorders.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01592149
• Other study ID #: 16235
• Status: Completed
• Phase: N/A
• First received: April 13, 2012
• Last updated: February 10, 2015
• Start date: May 2012
• Est. completion date: January 2015

Study information

• Verified date: February 2015
• Source: Bayer
• Contact: n/a
• Is FDA regulated: No
• Health authority: India: Drugs Controller General of India
• Study type: Observational

Clinical Trial Summary

The study is an epidemiological survey to find out the incidence of loss of appetite in Indian patients suffering from various health disorders. This survey will be conducted to obtain information on appetite from a total of 17500 subjects This study does not intend to study the effect of any drugs. The primary source of information will be the subjects themselves. The study will be conducted at 275 - 350 centres spread across India.This is a single visit study.The physician will conduct routine clinical, physical and general examination.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 16629
• Est. completion date: January 2015
• Est. primary completion date: March 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Men and Non-pregnant women = 18 years of age recuperating from healthcare disorders like:Malaria fever, Typhoid or enteric fever

• Hepatitis

• Acute infections including respiratory, urinary tract infections etc treated with antibiotic

• Tuberculosis

• Patient discharged from hospital after general surgical procedures like acute appendectomy, etc.

• Any other condition

Exclusion Criteria:

• Patients unwilling to provide informed consent & comply with the study procedure

• Patient using drugs which affect appetite like Cyproheptadine etc.

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Anorexia
• Appetite

Intervention

Other:
• No Drug
No intervention will be given to subjects, survey of loss of appetite in patients suffering from various healthcare disorders.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Bayer

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of patients with loss of appetite		1 Day	No
Secondary	Percentage of patients with fatigue		1 Day	No
Secondary	Distribution of fatigue among the patients with respect to disease		1 Day	No
Secondary	Percentage of patients with moderate to very severe Fatigue.		1 Day	No

External Links

•   Click here and search for drug information provided by the FDA.
•   Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.